This study investigates the impact of SARS-CoV-2 mutations on receptor binding and antibody neutralization. Using atomic force microscopy and molecular dynamics, the researchers found increased stability in the RBD-ACE2 complex for several variants of concern, particularly due to N501Y and E484Q mutations. While N501Y increased stability, it is unlikely to significantly affect antibody neutralization. The work provides detailed insights into the binding of SARS-CoV-2 variants and their impact on immunity.
Publisher
Nature Communications
Published On
Nov 30, 2021
Authors
Melanie Koehler, Ankita Ray, Rodrigo A. Moreira, Blinera Juniku, Adolfo B. Poma, David Alsteens
Tags
SARS-CoV-2
mutations
receptor binding
antibody neutralization
RBD-ACE2 complex
N501Y
E484Q
Related Publications
Explore these studies to deepen your understanding of the subject.